Ozempic has no BMI requirement. Unlike weight loss medications that set specific BMI thresholds, Ozempic is FDA-approved for adults with type 2 diabetes regardless of their body weight. The confusion comes from people mixing up Ozempic with Wegovy, its sister drug that does have BMI cutoffs for weight management.
Why Ozempic Doesn’t Have a BMI Threshold
Ozempic (semaglutide) is approved for three specific uses in adults with type 2 diabetes: improving blood sugar control alongside diet and exercise, reducing the risk of major cardiovascular events like heart attack and stroke in those with established heart disease, and protecting kidney function in those with chronic kidney disease. None of these indications mention BMI.
The FDA label actually states that Ozempic’s effectiveness “was not impacted by age, gender, race, ethnicity, BMI at baseline, body weight (kg) at baseline, diabetes duration and level of renal function impairment.” In other words, it works for people with type 2 diabetes across the full spectrum of body sizes. A doctor can prescribe Ozempic to someone with a BMI of 24 or 44, as long as they have type 2 diabetes.
Where the BMI Numbers Come From
The BMI thresholds you’ve likely seen online, 30 or 27, actually belong to Wegovy. Wegovy contains the same active ingredient as Ozempic (semaglutide) but at a higher maximum dose and with a different FDA approval. Wegovy is specifically approved for chronic weight management in adults who meet one of two criteria:
- BMI of 30 or higher (classified as obesity)
- BMI of 27 or higher with at least one weight-related health condition, such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnea
Ozempic is not approved for weight loss. It causes weight loss as a side effect, and many people seek it out for that reason, but the prescribing criteria are built around diabetes management, not body weight.
What You Actually Need to Get a Prescription
To qualify for Ozempic through its approved use, you need a diagnosis of type 2 diabetes. Your doctor will typically consider it when diet, exercise, and first-line medications like metformin aren’t bringing your blood sugar into a healthy range. Some prescribers start patients on Ozempic earlier if cardiovascular or kidney risk is a concern.
The standard dosing starts at 0.25 mg injected once a week for the first four weeks. This starting dose isn’t therapeutic; it’s designed to let your body adjust and minimize nausea. From there, the dose gradually increases. The maximum recommended dose is 2 mg once weekly, though many people find adequate blood sugar control at lower doses.
Off-Label Prescribing for Weight Loss
In practice, some doctors prescribe Ozempic off-label for weight loss in patients who don’t have type 2 diabetes. Off-label means the doctor is using their clinical judgment to prescribe a drug for a purpose the FDA hasn’t specifically approved. This is legal and common in medicine, but it comes with practical consequences.
Insurance companies typically won’t cover Ozempic for weight loss. They’ll check for a type 2 diabetes diagnosis, and without one, you’re likely looking at out-of-pocket costs. When doctors do prescribe semaglutide specifically for weight management, Wegovy is the approved option, and insurers are more likely to cover it when you meet the BMI criteria listed above. Coverage still varies widely by plan, and many insurers require documentation that you’ve tried lifestyle changes first.
Ozempic vs. Wegovy: Key Differences
Both drugs are semaglutide made by the same manufacturer. The differences are in the approved use, the dosing, and insurance coverage. Ozempic maxes out at 2 mg per week and is labeled for type 2 diabetes. Wegovy goes up to 2.4 mg per week and is labeled for chronic weight management with those BMI thresholds attached.
If your primary goal is blood sugar control and you have type 2 diabetes, Ozempic is the straightforward path with no BMI gate. If your primary goal is weight loss and you don’t have diabetes, Wegovy is the version designed for that purpose, and you’ll need to meet the BMI of 30 (or 27 with a qualifying condition) to be eligible under its label.